PUBLISHER: Grand View Research | PRODUCT CODE: 1529809
PUBLISHER: Grand View Research | PRODUCT CODE: 1529809
Transradial Access Devices Market Trends
The global transradial access devices market size was estimated at USD 2.1 billion in 2023 and is projected to grow at a CAGR of 7.8% from 2024 to 2030. The market is driven by several key factors such as the increasing prevalence of cardiovascular diseases, technological advancements in interventional cardiology procedures, and growing demand for minimally invasive surgeries. Furthermore, the increasing adoption of transradial access techniques by healthcare providers is expected to contribute significantly to the growth of the market.
The rising incidence of cardiovascular diseases globally is a significant driver for the market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of mortality worldwide, with an estimated 17.9 million deaths annually. In 2021, around 695,000 people died from heart disease in the U.S. that equates to one in every 5 deaths according to U.S. Centers for Disease Control and Prevention (CDC). This high prevalence of cardiovascular conditions necessitates the use of advanced medical devices such as transradial access devices for effective diagnosis and treatment.
Advancements in interventional cardiology procedures lead to the development of innovative transradial access devices that offer improved safety, efficacy, and patient outcomes. For instance, the introduction of hydrophilic coatings on sheaths reduces friction during radial artery cannulation, enhancing procedural success rates. Technological advancements result in a lower rate of access site complications and improved patient comfort during transradial interventions.
The shift towards minimally invasive procedures across various medical specialties is fueling the demand. Patients prefer minimally invasive surgeries due to shorter hospital stays, faster recovery times, and reduced risk of complications compared to traditional open surgeries. This trend positively impacts the adoption of transradial access techniques and devices in clinical practice. For instance, in September 2023, MicroVention, a neurovascular company and a subsidiary of Terumo Corporation, announced that its Sofia EX 5-F, 115-cm intracranial support catheter has received FDA 510(k) clearance for use with both transradial and transfemoral access methods. This expanded clearance enables healthcare providers to utilize the Sofia EX 5-F catheter in a wider range of procedures, providing them with greater flexibility and versatility when treating patients.
Global Transradial Access Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global transradial access devices market report based on product, end-use, application, and region.
U.S.
Canada
Mexico
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
China
Japan
India
South Korea
Australia
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait